Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats

J Mao1, D D Price, J Lu

  • 1Department of Anesthesiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.

Neuroscience Letters
|August 26, 1998
PubMed

Insights

Spinal cord mu-opioid and N-methyl-D-aspartate (NMDA) receptor interactions contribute to antinociceptive tolerance. Blocking NMDA receptors with MK-801 prevented tolerance to the mu-opioid agonist DAMGO.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Morphine's interaction with spinal cord mu-opioid and N-methyl-D-aspartate (NMDA) receptors is implicated in antinociceptive tolerance.
  • Morphine acts on mu-receptors but also other opioid receptor subtypes.

Purpose of the Study:

  • To investigate the role of spinal cord mu-opioid and NMDA receptor interactions in antinociceptive tolerance.
  • To test the hypothesis using a selective mu-opioid agonist, D-Ala2-N-Me-Phe4,Gly-ol5-enkephalin (DAMGO).

Main Methods:

  • Repeated intrathecal (i.t.) administration of DAMGO (6 microg, twice daily for 7 days) in rats.
  • Assessment of antinociceptive tolerance using the tail-flick test on Day 8.
  • Co-administration of DAMGO with NMDA receptor antagonist MK-801 to evaluate prevention of tolerance.

Main Results:

  • Repeated DAMGO administration induced a significant rightward shift (approx. 17-fold) in the dose-response curve, indicating antinociceptive tolerance.
  • Co-administration of MK-801 with DAMGO effectively prevented this induced antinociceptive tolerance.
  • A lower dose range of MK-801 also prevented tolerance to a lower dose of DAMGO.

Conclusions:

  • The results support a model of opioid tolerance involving spinal cord interactions between mu-opioid and NMDA receptors.
  • This highlights the cellular and intracellular mechanisms underlying opioid tolerance.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...